| Literature DB >> 26282880 |
Hao Wang1,2, Dandan Zhang1,2, Jie Ling3, Wenhui Lu1,2, Shuai Zhang1,2, Yimin Zhu3, Maode Lai1,2.
Abstract
Hepatic lipase (LIPC) is a key rate-limiting enzyme in lipoprotein catabolism pathways involved in the development of obesity. The C-514T polymorphism in the promoter region is associated with decreased LIPC activity. We performed a case-controlled study (850 obese children and 2119 controls) and evaluated the association between LIPC C-514T polymorphism, obesity and plasma lipid profile in Chinese children and adolescents. Additionally, we conducted a meta-analysis of all results from published studies as well as our own data. A significant association between the polymorphism and obesity is observed in boys (P = 0.042), but not in girls. And we observed a significant relationship of the polymorphism with total cholesterol (TC) and high density lipoprotein cholesterol (HDL-C) independent of obesity in boys. The T allele carriers have higher levels of low density lipoprotein cholesterol (LDL-C) in obese boys, and triglyceride (TG), TC and LDL-C in non-obese girls (all P < 0.05). In the meta-analysis, under dominant model the T allele increased body mass index (BMI) level in boys, while it decreased BMI in girls, and increased the levels of TC both in the overall and subgroups, TG and HDL-C in the overall and boys, and LDL-C in the overall (all P < 0.05). Our results suggest that the T allele might carry an increased risk of obesity in Chinese boys. The meta-analysis suggests that T allele acts as a risk allele for higher BMI levels in male childhood, while it is a protective allele in female childhood. And the polymorphism is associated with the levels of plasma lipids, which may be modulated by obesity and gender.Entities:
Keywords: children; lipids; obesity; polymorphism
Mesh:
Substances:
Year: 2015 PMID: 26282880 PMCID: PMC4568933 DOI: 10.1111/jcmm.12663
Source DB: PubMed Journal: J Cell Mol Med ISSN: 1582-1838 Impact factor: 5.310
Anthropometric, biochemical and genetic characteristics of the subjects
| Characteristics | Obesity ( | Normal weight ( | |
|---|---|---|---|
| Age (years) | 11.2 ± 2.8 | 11.6 ± 2.5 | <0.001 |
| Gender, | |||
| Boys | 565 (66.5) | 1376 (64.9) | 0.443 |
| Girls | 285 (33.5) | 743 (35.1) | |
| Height (cm) | 150.5 ± 15.7 | 146.9 ± 16.2 | <0.001 |
| Weight (kg) | 62.4 ± 20.0 | 38.0 ± 11.9 | <0.001 |
| TG (mmol/l) | 1.23 ± 0.63 | 0.78 ± 0.36 | <0.001 |
| TC (mmol/l) | 4.23 ± 0.79 | 3.87 ± 0.72 | <0.001 |
| LDL-C (mmol/l) | 2.40 ± 0.66 | 1.96 ± 0.54 | <0.001 |
| HDL-C (mmol/l) | 1.33 ± 0.40 | 1.51 ± 0.38 | <0.001 |
Independent t-test.
Chi-squared test.
Continuous variables are presented as mean ± S.D.
TG: triglyceride; TC: total cholesterol; LDL-C: low density lipoprotein cholesterol-cholesterol; HDL-C: high density lipoprotein cholesterol.
Association between LIPC C-514T genotype and obesity
| Genotypes | Obesity, | Normal weight, | OR (95%CI) |
|
|---|---|---|---|---|
| All | ||||
| CC | 307 (36.1) | 831 (39.2) | 1 | 0.069 |
| CT | 407 (47.9) | 994 (46.9) | 1.11 (0.93–1.32) | |
| TT | 136 (16.0) | 294 (13.9) | 1.24 (0.97–1.58) | |
| 0.061 | ||||
| Boys | ||||
| CC | 200 (35.4) | 549 (39.9) | 1 | 0.042 |
| CT | 272 (48.1) | 637 (46.3) | 1.17 (0.94–1.45) | |
| TT | 93 (16.5) | 190 (13.8) | 1.34 (0.99–1.80) | |
| 0.038 | ||||
| Girls | ||||
| CC | 107 (37.5) | 282 (38.0) | 1 | 0.784 |
| CT | 135 (47.4) | 357 (48.0) | 1.01 (0.75–1.36) | |
| TT | 43 (15.1) | 104 (14.0) | 1.07 (0.70–1.63) | |
| 0.752 | ||||
P-value was calculated by logistic regression adjust for age.
P-value for trend was calculated by chi-squared test.
Stratified analysis of LIPC C-514T genotype and gender in association with plasma lipid concentrations by obesity
| Variables | Normal weight |
| Obesity |
| ||||
|---|---|---|---|---|---|---|---|---|
| CC | CT/TT | CC | CT/TT | |||||
| TG (mmol/l) | ||||||||
| Boys | 0.74 ± 0.38 | 0.75 ± 0.32 | 0.804 | 0.048 | 1.23 ± 0.64 | 1.24 ± 0.68 | 0.821 | 0.247 |
| Girls | 0.81 ± 0.32 | 0.88 ± 0.39 | 0.012 | 1.18 ± 0.49 | 1.28 ± 0.63 | 0.111 | ||
| TC (mmol/l) | ||||||||
| Boys | 3.74 ± 0.64 | 3.83 ± 0.68 | 0.010 | 0.540 | 4.12 ± 0.77 | 4.29 ± 0.74 | 0.015 | 0.894 |
| Girls | 3.92 ± 0.72 | 4.06 ± 0.81 | 0.026 | 4.11 ± 0.84 | 4.29 ± 0.88 | 0.097 | ||
| LDL-C (mmol/l) | ||||||||
| Boys | 1.86 ± 0.48 | 1.90 ± 0.49 | 0.171 | 0.162 | 2.32 ± 0.57 | 2.44 ± 0.62 | 0.028 | 0.640 |
| Girls | 2.04 ± 0.53 | 2.14 ± 0.64 | 0.022 | 2.30 ± 0.71 | 2.46 ± 0.79 | 0.073 | ||
| HDL-C (mmol/l) | ||||||||
| Boys | 1.47 ± 0.35 | 1.53 ± 0.38 | 0.001 | 0.153 | 1.26 ± 0.34 | 1.34 ± 0.39 | 0.011 | 0.260 |
| Girls | 1.52 ± 0.37 | 1.53 ± 0.38 | 0.647 | 1.34 ± 0.48 | 1.38 ± 0.44 | 0.758 | ||
Continuous variables are presented as mean ± S.D.
P-value was calculated in the linear regression model adjusted for age.
TG: triglyceride; TC: total cholesterol; LDL-C: low density lipoprotein cholesterol-cholesterol; HDL-C: high density lipoprotein cholesterol.
Characteristics of the included studies in meta-analysis
| Author | Year | Region/ethnicity | Age | Genotyping assay | Sample size | Genotype frequencies (%) | HWE | ||
|---|---|---|---|---|---|---|---|---|---|
| Boys/girls | CC | CT | TT | ||||||
| Chen | 2003 | American whites | 4–17 years | TaqMan assay | 969/1450 | 1481 (61.22) | 817 (33.78) | 121 (5.00) | 0.54 |
| Chen | 2003 | American blacks | 4–17 years | TaqMan assay | 395/666 | 223 (21.02) | 530 (49.95) | 308 (29.03) | 0.86 |
| Riestra | 2009 | Spain | 6–8 years | Restriction fragment length polymorphism (RFLP) | 634/626 | 762 (60.48) | 456 (36.19) | 42 (3.33) | 0.01 |
| Agirbasli | 2013 | Turkish | 6–17 years | Restriction fragment length polymorphism (RFLP) | 170/190 | 244 (67.78) | 105 (29.17) | 11 (3.05) | 0.94 |
| Present study | 2010 | Chinese | 6–17 years | Sequenom MassARRAY iPLEX | 1941/1028 | 1138 (38.33) | 1401 (47.19) | 430 (14.48) | 0.97 |
HWE P-value is 0.001 in boys and 0.55 in girls.
HWE: Hardy–Weinberg equilibrium.
Figure 1Forest plots of the association of LIPC C-514T polymorphism with BMI and plasma lipids. (A) BMI; (B) TG; (C) TC; (D) LDL-C; (E) HDL-C. BMI: body mass index; TG: triglyceride; TC: total cholesterol; LDL-C: low density lipoprotein cholesterol; HDL-C: high density lipoprotein cholesterol.
Figure 2Sensitivity analysis for the association of LIPC C-514T polymorphism with BMI and plasma lipids. (A) BMI; (B) TG; (C) TC; (D) LDL-C; (E) HDL-C. See Figure1 for abbreviations.
Figure 3Begg’s funnel plots of the association of LIPC C-514T polymorphism with BMI and plasma lipids. (A) BMI; (B) TG; (C) TC; (D) LDL-C; (E) HDL-C. See Figure1 for abbreviations.